171 related articles for article (PubMed ID: 11091130)
21. Rapid and persistent desensitization of m3 muscarinic acetylcholine receptor-stimulated phospholipase D. Concomitant sensitization of phospholipase C.
Schmidt M; Fasselt B; Rümenapp U; Bienek C; Wieland T; van Koppen CJ; Jakobs KH
J Biol Chem; 1995 Aug; 270(34):19949-56. PubMed ID: 7650010
[TBL] [Abstract][Full Text] [Related]
22. Altered cardiovascular responses in mice lacking the M(1) muscarinic acetylcholine receptor.
Hardouin SN; Richmond KN; Zimmerman A; Hamilton SE; Feigl EO; Nathanson NM
J Pharmacol Exp Ther; 2002 Apr; 301(1):129-37. PubMed ID: 11907166
[TBL] [Abstract][Full Text] [Related]
23. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
24. Coupling of muscarinic m1, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins.
Burford NT; Tobin AB; Nahorski SR
Eur J Pharmacol; 1995 Apr; 289(2):343-51. PubMed ID: 7621908
[TBL] [Abstract][Full Text] [Related]
25. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
26. The assessment of antagonist potency under conditions of transient response kinetics.
Christopoulos A; Parsons AM; Lew MJ; El-Fakahany EE
Eur J Pharmacol; 1999 Oct; 382(3):217-27. PubMed ID: 10556673
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonists.
Christopoulos A; Grant MK; Ayoubzadeh N; Kim ON; Sauerberg P; Jeppesen L; El-Fakahany EE
J Pharmacol Exp Ther; 2001 Sep; 298(3):1260-8. PubMed ID: 11504829
[TBL] [Abstract][Full Text] [Related]
28. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.
Griffin MT; Figueroa KW; Liller S; Ehlert FJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):1193-207. PubMed ID: 17392404
[TBL] [Abstract][Full Text] [Related]
29. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
30. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
Michal P; Lysíková M; Tucek S
Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
[TBL] [Abstract][Full Text] [Related]
31. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
33. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
Olianas MC; Maullu C; Onali P
Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
[TBL] [Abstract][Full Text] [Related]
34. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
[TBL] [Abstract][Full Text] [Related]
35. Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors.
Potter PE; Gaughan C; Assouline Y
Neuropharmacology; 1999 Apr; 38(4):579-86. PubMed ID: 10221761
[TBL] [Abstract][Full Text] [Related]
36. Investigating the interaction of McN-A-343 with the M muscarinic receptor using its nitrogen mustard derivative and ACh mustard.
Figueroa KW; Suga H; Ehlert FJ
Br J Pharmacol; 2010 Jul; 160(6):1534-49. PubMed ID: 20590642
[TBL] [Abstract][Full Text] [Related]
37. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
[TBL] [Abstract][Full Text] [Related]
39. The mechanism of muscarinic agonist-stimulated inositol phosphate formation in permeabilized ileal smooth muscle.
Honda K; Takano Y; Kamiya H
Jpn J Pharmacol; 1994 Jul; 65(3):275-80. PubMed ID: 7799528
[TBL] [Abstract][Full Text] [Related]
40. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes.
Feron O; Smith TW; Michel T; Kelly RA
J Biol Chem; 1997 Jul; 272(28):17744-8. PubMed ID: 9211926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
